A chronic wound isn’t just a slow-healing injury or a wound that won’t heal. For millions of Medicare patients, it threatens their independence. For you, the provider, chronic wound treatment represents a complex clinical challenge.
When standard dressings and basic debridement fail to produce results, sticking to the status quo isn't an option.
To improve outcomes, we have to understand why traditional care stops working and how modern biologics can restart the healing process.
Standard of Care (SOC) usually involves moist wound therapy, debridement, and infection control. While this works for acute (fresh) wounds, SOC often falls short for chronic cases. The reason lies in the molecular environment of the wound.
These wounds often get stuck in a chaotic state of inflammation. High levels of enzymes called matrix metalloproteinases (MMPs) eat away at growth factors and essential proteins faster than the body can make them.
On top of that, biofilm is present in all chronic wounds. Without effective debridement, this bacterial shield makes many topical treatments useless and prevents healing.
Before you can treat the wound effectively, you must break these barriers. And basic dressings cannot fix these underlying biological issues.
When a wound stalls, it needs a wake-up call. This is where advanced chronic wound treatment using biologic skin substitutes makes a difference.
Unlike passive dressings that just cover the area, these products are active healing participants.
● Bioactive Matrix. It rebuilds the frame (extracellular matrix), giving cells a fresh scaffold to climb and grow on.
● Growth Factor Delivery. They bring in essential signaling molecules that chronic wounds are missing.
● Recruiting Stem Cells. They signal the body’s own stem cells to come to the injury site and start repairing.
Switching to a biologic approach helps turn a stalled, chronic environment into an acute, healing one.
Shifting to advanced modalities offers clear benefits. Studies show that using cellular and tissue-based products (CTPs) significantly increases the percentage of wounds that close completely.
For your patient, effective chronic wound treatment means less pain, better mobility, and a lower risk of severe complications like bone infection or amputation.
For your practice, it means treating patients more effectively, freeing up your schedule, and providing a higher standard of care.
The admin of adopting advanced therapies can be overwhelming. Insurance pre-authorizations, product ordering, and billing rules often stop providers from using the best tools available. RenewMed exists to solve this problem. We’re your distributor and support, streamlining the business side of wound care.
Our White Glove Service:
● Assigns a Personal Consultant to your practice to manage the logistics.
● Handles the Insurance Verification Requests (IVR) to ensure patient eligibility.
● Provides the documentation templates you need to prove medical necessity.
● Ensures our products are on the Medicare Average Sales Price (ASP) list, for a smoother, faster reimbursement for your practice.
By managing the 'business' of medicine, we let you focus entirely on the 'practice' of medicine.
It is a wound that has not healed or significantly improved after 30 days of standard care.
Poor blood flow, diabetes, and prolonged pressure are the most common causes. These issues stop the natural healing process.
Biofilm acts like a shield for bacteria, protecting them from antibiotics and the immune system. This keeps the wound inflamed and prevents healing.
If you don't see the wound shrink by about 50% after 4 weeks of optimal standard care, it's time to look at advanced therapies.
Yes. We offer a portfolio of products and can provide clinical information to help you select the best graft for the specific wound type.
Yes. Our billing partners specialize in wound care. They can help you manage claims and appeals to protect your revenue.
It can be tricky. However, our White Glove Service includes access to billing partners who help with claims and appeals.
Effective chronic wound treatment means using better tools when basic care fails. By using advanced biologics and a partner who handles the administrative burden, you ensure your patients get the best chance to heal. CTA: Reach out to RenewMed today. We’ll help you stop managing wounds and start healing them.
Advance your health. Empowering providers, healing patients.
Sources Used 1. https://www.mdpi.com/2077-0383/14/22/8121 2. https://pmc.ncbi.nlm.nih.gov/articles/PMC5426882/ 3. https://woundsinternational.com/wp-content/uploads/2024/12/MULTI24_CD_Skin-substitues_WINT_WEB.pdf 4. https://pubmed.ncbi.nlm.nih.gov/39841083/ 5. https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id109TA.pdf
Disclaimer: This content is created for licensed healthcare professionals, offering educational insights into wound care. It is not intended as medical advice or to replace your own clinical judgment when treating patients. We're here to support you, but the final treatment decisions should always be based on your professional evaluation of each unique patient's needs.
